Timothy Daley
Stock Analyst at Wells Fargo
(2.50)
# 2,287
Out of 4,711 analysts
58
Total ratings
51.43%
Success rate
0.52%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $45 | $44.67 | +1.46% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $13.36 | +49.70% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $112.56 | -15.60% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $57.00 | +26.32% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $134.51 | +7.80% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,230.74 | +5.63% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $368.16 | -22.59% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $228.55 | +8.07% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $185.77 | +48.03% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $228.61 | +18.11% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $12.04 | +132.56% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $20.56 | +70.23% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $524.05 | -0.77% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $4.08 | +120.59% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $144.46 | +28.06% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $71.65 | +18.63% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $197.27 | +11.52% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $207.51 | +6.02% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $21.21 | +32.01% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $153.10 | -8.56% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $73.17 | +23.00% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $45
Current: $44.67
Upside: +1.46%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $13.36
Upside: +49.70%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $112.56
Upside: -15.60%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $57.00
Upside: +26.32%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $134.51
Upside: +7.80%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,230.74
Upside: +5.63%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $368.16
Upside: -22.59%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $228.55
Upside: +8.07%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $185.77
Upside: +48.03%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $228.61
Upside: +18.11%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $12.04
Upside: +132.56%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $20.56
Upside: +70.23%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $524.05
Upside: -0.77%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $4.08
Upside: +120.59%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $144.46
Upside: +28.06%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $71.65
Upside: +18.63%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $197.27
Upside: +11.52%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $207.51
Upside: +6.02%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $21.21
Upside: +32.01%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $153.10
Upside: -8.56%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $73.17
Upside: +23.00%